Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Uncomplicated Plasmodium Falciparum”

205 trials

Showing 20 of 205 results

Post-approval studies (Phase 4)Study completedNCT01697787
What this trial is testing

Amodiaquine-Artesunate & Artemether-Lumefantrine Efficacy in Burkina Faso

Who this might be right for
Malaria
Centre Muraz 150
Large-scale testing (Phase 3)Study completedNCT00682578
What this trial is testing

A Comparative Study of Artekin With Standard Malarial Treatment Regimes in Afghanistan

Who this might be right for
Uncomplicated Falciparum MalariaVivax Malaria
University of Oxford 1,086
Testing effectiveness (Phase 2)Looking for participantsNCT07811908
What this trial is testing

Platform Study to Evaluate the Efficacy and Safety of Anti-malarial Agents in Participants With Uncomplicated Plasmodium Falciparum Malaria (Cohort C2)

Who this might be right for
Uncomplicated Plasmodium Falciparum Malaria
Novartis Pharmaceuticals 120
Large-scale testing (Phase 3)Study completedNCT03452475
What this trial is testing

Comparison of Arterolane-piperaquine Versus Arterolane-piperaquine+Mefloquine Versus Artemether-lumefantrine in Kenyan Children

Who this might be right for
Plasmodium Falciparum
University of Oxford 219
Post-approval studies (Phase 4)Study completedNCT06076213
What this trial is testing

Test Efficacy Study on the Recommended Antimalarial Drugs in the Democratic Republic of the Congo

Who this might be right for
Uncomplicated Plasmodium Falciparum Malaria
Ministry of Public Health, Democratic Republic of the Congo 1,260
Post-approval studies (Phase 4)Study completedNCT03453840
What this trial is testing

Extended Duration Artemether-lumefantrine Treatment for Malaria in Children

Who this might be right for
Uncomplicated Plasmodium Falciparum Malaria
University of California, San Francisco 305
Post-approval studies (Phase 4)Study completedNCT01017770
What this trial is testing

Artemether-lumefantrine (AL) Versus Artesunate + Amodiaquine (ASAQ) for the Treatment of Uncomplicated Falciparum Malaria in Burkina Faso

Who this might be right for
Uncomplicated P. Falciparum Malaria in Children
Centre Muraz 340
Post-approval studies (Phase 4)Study completedNCT03768908
What this trial is testing

Efficacy of Artesunate + Amodiaquine Versus Artemether-lumefantrine for Falciparum Malaria in Zanzibar, 2005

Who this might be right for
Plasmodium Falciparum Malaria
Professor Anders Björkman 359
Testing effectiveness (Phase 2)Study completedNCT00959517
What this trial is testing

Trial of Artesunate Combination Therapy in Pakistan

Who this might be right for
Uncomplicated Falciparum Malaria
London School of Hygiene and Tropical Medicine 588
Large-scale testing (Phase 3)Study completedNCT00367653
What this trial is testing

Azithromycin Plus Chloroquine Versus Mefloquine In the Treatment of Uncomplicated P. Falciparum Malaria.

Who this might be right for
Malaria
Pfizer 397
Not applicableStudy completedNCT01115439
What this trial is testing

Artesunate+Sulfadoxine-Pyrimethamine for the Treatment of Uncomplicated Falciparum Malaria

Who this might be right for
Falciparum Malaria
University of Oxford 100
Testing effectiveness (Phase 2)Study completedNCT02389439
What this trial is testing

Efficacy and Safety of Pyronaridine-artesunate for the Treatment in Uncomplicated Falciparum Malaria

Who this might be right for
Malaria, Falciparum
University of Oxford 123
Testing effectiveness (Phase 2)Active Not RecruitingNCT06040346
What this trial is testing

Open-Label Study to Assess Meplazumab in Adult Patients Diagnosed with Plasmodium Falciparum

Who this might be right for
Malaria
Jiangsu Pacific Meinuoke Bio Pharmaceutical Co Ltd 60
Large-scale testing (Phase 3)Study completedNCT05764746
What this trial is testing

Triple Artemisinin-based Combination Therapy for Delaying Drug Resistance Development - a Randomized Clinical Trial

Who this might be right for
Uncomplicated Plasmodium Falciparum Malaria
Muhimbili University of Health and Allied Sciences 384
Large-scale testing (Phase 3)WithdrawnNCT00936767
What this trial is testing

Artemisone for the Treatment of Uncomplicated Falciparum Malaria in Western Cambodia

Who this might be right for
Uncomplicated Falciparum Malaria
University of Oxford
Post-approval studies (Phase 4)Study completedNCT00529867
What this trial is testing

Randomised Efficacy Study of Two Artemether-Lumefantrine Oral Formulations for the Treatment of Uncomplicated P. Falciparum Malaria

Who this might be right for
Malaria, Falciparum
Dafra Pharma 267
Post-approval studies (Phase 4)Temporarily pausedNCT00465257
What this trial is testing

Efficacy of Artesunate + Amodiaquine Four Years After Its Introduction in Zanzibar

Who this might be right for
Malaria
Karolinska University Hospital 110
Testing effectiveness (Phase 2)Study completedNCT00243737
What this trial is testing

Efficacy, Safety and Pharmacokinetic of ArtequinTM P. Falciparum Malaria

Who this might be right for
Malaria
Albert Schweitzer Hospital 70
Early research (Phase 1)Study completedNCT02612545
What this trial is testing

Efficacy, Safety, and Tolerability of Dihydroartemisinin-piperaquine + Mefloquine Compared to Dihydroartemisinin-piperaquine or Artesunate-mefloquine in Patients With Uncomplicated Falciparum Malaria in Cambodia

Who this might be right for
Acute Falciparum Malaria
National Institute of Allergy and Infectious Diseases (NIAID) 216
Large-scale testing (Phase 3)Study completedNCT02020330
What this trial is testing

Optimising Operational Use of Artemether-lumefantrine Comparing 3 Day Versus 5 Day

Who this might be right for
Plasmodium Falciparum Infection
University of Oxford 150
Next Page

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation